Thursday, 22 June 2023, 13:00 (CEST) - 18:30 (CEST)


European Medicines Agency, Amsterdam, the Netherlands

Event summary

Accelerating Clinical Trials in the EU (ACT EU) Priority Action 3 aims to establish a platform where all stakeholders involved in designing, regulating, performing and participating in clinical trials can, through regular dialogue, identify relevant scientific, methodological and technological advances to develop the clinical trials environment in the EU.

Through a series of workshops to be held in 2023 and 2024, an EU multi-stakeholder platform on clinical trials will be established to advance discussions on priority topics by efficiently incorporating the views, needs and concerns of all parties involved in the process.

This two-day event offered participants the opportunity to:

•    understand different stakeholder perspectives on how to transform the EU environment for clinical trials;
•    Present and discuss the feedback obtained during the MSP public consultation;
•    Initiate discussion on priority areas identified during the public stakeholder consultation;
•    Present and discuss a proposed model for the establishment of the MSP in ACT EU.

A video recording is available below.

The meeting report is available on the ACT EU website:

Video recording

Day 1 

Day 2



How useful do you find this page?